iVoox
iVoox Podcast & radio
Download app for free
By Society of Surgical Oncology SurgOnc Today
Neoadjuvant Therapy Trials for Pancreas Cancer Conundrum: The European Take: PREOPANC2, NORPACT

Neoadjuvant Therapy Trials for Pancreas Cancer Conundrum: The European Take: PREOPANC2, NORPACT

8/1/2024 · 21:41
0
0
SurgOnc Today Episode of SurgOnc Today

Description of Neoadjuvant Therapy Trials for Pancreas Cancer Conundrum: The European Take: PREOPANC2, NORPACT

In this episode of SurgOnc Today®, Akhil Chawla, MD, from Northwestern University, and a member of the SSO HPB disease site working group, is joined by Bas Groot Koerkamp, MD, PhD, from Erasmus Medical Centre and Knut Jørgen Labori, MD, PhD, from Oslo University Hospital. They discuss the details, similarities, and differences of their respective clinical trials for neoadjuvant therapy for pancreatic adenocarcinoma, NORPACT-1 and PREOPANC2.
References/Resources: NORPACT-1 results: https://www.sciencedirect.com/science/article/abs/pii/S2468125323004053?via%3Dihub NORPACT-1 editorial: https://pubmed.ncbi.nlm.nih.gov/38604195/ PREOPANC-2 protocol: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08031-z PREOPANC-2 results : https://www.annalsofoncology.org/article/S0923-7534(23)04228-X/fulltext

Comments of Neoadjuvant Therapy Trials for Pancreas Cancer Conundrum: The European Take: PREOPANC2, NORPACT
This program does not accept anonymous comments. !Sign up to comment!